Short incubation photodynamic therapy with methylaminolevulinate and no occlusion for the treatment of actinic keratoses - 14/11/12
Doi : 10.1016/j.jaad.2012.05.039
Robert Bissonnette, MD, FRCPC ⁎ 
, Chantal Bolduc, MD, FRCPC, Catherine Maari, MD, FRCPC, Simon Nigen, MD, FRCPC
, Chantal Bolduc, MD, FRCPC, Catherine Maari, MD, FRCPC, Simon Nigen, MD, FRCPC Innovaderm Research Inc., Montreal, Quebec, Canada
Correspondence to: Robert Bissonnette, MD, FRCPC, 1851 Sherbrooke St. East, Suite 502, Montreal, Quebec, H2K 4L5, Canada.| Funding sources: Galderma Canada Inc. (for research and provision of medication). |
|
| Conflicts of interest: Drs Bissonnette, Bolduc, Maari, and Nigen have been speakers, consultants, advisory board members and/or investigators and have received honoraria and/or grants from DUSA Pharmaceuticals, Galderma Canada, Graceway, Valeant Pharma, and/or Photocure ASA. |
|
| Reprints not available from the authors. |
© 2012
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 67 - N° 6
P. 1386-1387 - décembre 2012 Retour au numéro
Article précédent
- The current state of dermatology training: A national survey of graduating dermatology residents
- Neelam A. Vashi, Jo-Ann Latkowski
- Pain and nonmelanoma skin cancer in transplant patients
- Shawn G. Kwatra, Kyle C. Mills, Alex Zeitany, Daniel J. Pearce, Phillip M. Williford, Ralph B. D’Agostino, Gil Yosipovitch
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?